Brian is a Principal Scientist in the Quantitative Pharmacology and Pharmacometrics group at MSD. Here he has served as the clinical pharmacology and pharmacometrics lead for several antiviral programs, including MSD’s molnupiravir. Brian holds a PharmD from the University of Florida, where he conducted research on evaluating the bioequivalence of inhaled drug products. He then completed a fellowship in pharmacometrics at the University of North Carolina with a research focus on PK of HIV antiretrovirals and minimal PBPK modeling. His research interests are in infectious disease/vaccines, pediatrics, and comparator modeling.